Besponsa

Inotuzumab Ozogamicin

8.8 High risk

Besponsa & Neoplasm progression

15.1%

of users reported Neoplasm progression

73.1%

also reported Death

72.4%

are men

Most common medical consequences

Death
73.1%
Severe reaction
19.4%
Hospitalization
7.5%

Have you experienced any negative side effects from this medication?

Besponsa: general information

Most common side effects (21)

Most commonly affected ages

0 - 9 years
7.7%
10 - 19 years
12.4%
20 - 29 years
8.2%
30 - 39 years
5.2%
40 - 49 years
11.7%
50 - 59 years
10.2%
60 - 69 years
9.7%
70 - 79 years
25.4%
80 - 89 years
9.5%
On this page
Besponsa & Neoplasm progression
Besponsa: general information